Employees Retirement System of Texas’s Supernus Pharmaceuticals SUPN Stock Holding History

Employees Retirement System of Texas’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-14,000	Closed	-$463K	–	1094
2019 Q2	$463K	Sell	14,000 -7,000	-33%	-$240K	0.01%	993
2019 Q1	$736K	Hold	21,000	–	–	0.01%	882
2018 Q4	$698K	Hold	21,000	–	–	0.01%	880
2018 Q3	$1.06M	Hold	21,000	–	–	0.01%	840
2018 Q2	$1.26M	Sell	21,000 -4,000	-16%	-$207K	0.02%	783
2018 Q1	$1.15M	Sell	25,000 -15,000	-38%	-$626K	0.02%	791
2017 Q4	$1.59M	Sell	40,000 -8,000	-17%	-$316K	0.02%	700
2017 Q3	$1.92M	Buy	48,000 +13,000	+37%	+$563K	0.03%	652
2017 Q2	$1.51M	Buy	+35,000	New	+$1.25M	0.02%	721
2016 Q3	–	Sell	-28,000	Closed	-$570K	–	983
2016 Q2	$570K	Buy	+28,000	New	+$497K	0.01%	859

Other funds holding SUPN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Employees Retirement System of Texas's SUPN Position: Q3 2019 in Review

Employees Retirement System of Texas sold out of Supernus Pharmaceuticals (SUPN) in Q3 2019, closing a stake of 14,000 shares — an estimated $463K sold.

Employees Retirement System of Texas first reported a position in SUPN in Q2 2016 and held it in 10 quarters. The position peaked at $1.92M in Q3 2017. 243 funds tracked by Wall St. Rank hold SUPN as of Q3 2019.

Employees Retirement System of Texas reported no remaining Supernus Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Employees Retirement System of Texas sold 14,000 Supernus Pharmaceuticals shares in Q3 2019, an estimated $463K.
Employees Retirement System of Texas first reported a position in Supernus Pharmaceuticals in Q2 2016 and held it in 10 quarters.
Employees Retirement System of Texas's Supernus Pharmaceuticals position peaked at $1.92M in Q3 2017.
243 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2019.

Based on Employees Retirement System of Texas's 13F filing for Q3 2019, filed 12 Nov 2019.